Univariate analysis showed that the difference between the BRCA1/2 mutant group and the wild-type group in terms of distant metastasis was statistically significant (P = 0.002), indicating that ovarian cancer patients with BRCA1/2 gene mutations are more likely to develop disease distant metastasis. Here, BRCA1 is linked to ovarian cancer.